• Media

Latest News

Display # 
Title Created Date
Cannabis Science Announces Preclinical Development Program for CS-TATI-I, Commencing EU Operations in the Netherlands and Sourcing Proprietary Material for Pharmacokinetic Characterization 26-04-13
Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18 16-04-13
Cannabis Science, Inc. Appoints Michael McGrath, MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine, UCSF, and Co-Founder of Biotechs Pathologica LLC and Neuraltus Pharmaceuticals, to the Company's Scientific Advisory Board 27-03-13
Cannabis Science Appoints Richard Ogden, PhD, Former Director of Scientific Affairs, HIV, Pfizer, as Chief Scientific Officer 27-02-13
Cannabis Science, Inc. Appoints Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics and Oncology and a Member of the Center for RNA Biology at the University of Rochester, School of Dentistry and Medicine, to Company's Scientific Advisory Board 12-02-13
CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to Better Meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance Among People with AIDS, & Increasing Need for Patient Friendly Skin Cancer Therapies 31-01-13
Cannabis Science, Inc., World AIDS Institute and Timothy Ray Brown Foundation Hold Special Event Tomorrow, December 15, in Las Vegas: 'All I Want For Christmas is a Cure' 14-12-12
Cannabis Science Appoints Dr. Michael J. Goldblatt, the Former Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), to its Scientific Advisory Board 26-11-12
Cannabis Science, Inc. Appoints Harvard Law School Graduate Chad S. Johnson, Esq. as a Member of the Company's Board of Directors and as General Counsel 13-11-12
Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Science's Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma 12-11-12
Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call 09-11-12
NBC News Reports History Being Made as Legalization For Colorado and Washington State Optimistically Impacts Growth For Cannabis Science's New Drug Development Programs and State-by-State Medicinal Initiatives 07-11-12
Cannabis Science Appoints Christopher Meenan MS, MBA as Executive Vice President of Product Research and Development 02-11-12
Cannabis Science is Encouraged by ASA's Challenge; the Appeals Court Hears Case on Rescheduling of the Case on the Medicinal Value of Cannabinoids 18-10-12
Cannabis Science and World AIDS Institute Announce Appointment of Dr. Robert Melamede to Scientific Advisory Board 10-10-12
Cannabis Science Initiates Preclinical Investigation of CS-TATI-1 for European Studies for Squamous/Basal Cell Carcinomas and Kaposi’s Sarcoma 24-09-12
NBC News Reports that Cannabidiol (CBD) "Turns Off" the Cancer Gene Involved in Metastasis Findings by Scientists at California Pacific Medical Center gives Scientific Support for Cannabis Science Initiatives 20-09-12
Cannabis Science Appoints Ronald Sekura PH.D former Food and Drug Administration (FDA) Research Chemist, Center for Biologics Evaluation and Review; as Executive Vice President of Regulatory Affairs 13-09-12
Cannabis Science Appoints Dr. J. Thomas August Professor, Pharmacology and Molecular Sciences, and Oncology at The Johns Hopkins University School of Medicine to the CBIS Scientific Advisory Board 24-08-12
Cannabis Science Announces Initiation of GMP Development Plan for CS-TATI-1 13-08-12

Media Menu

CBIS Latest News

Connect With Us


Facebook  Twitter  This email address is being protected from spambots. You need JavaScript enabled to view it. Go to USTREAM

People Behind the Scenes

Dr. Robert Melamede, Ph.D.
"The endocannabinoid system provides unique opportunities for regulating homeostasis to promote health with phyto-cannabinoid based pharmaceuticals."
Meet Dr. Robert Melamede, Ph.D. >